tiprankstipranks
ONO Pharmaceutical Co Ltd (OPHLF)
OTHER OTC:OPHLF
US Market

ONO Pharmaceutical Co (OPHLF) Income Statement

Compare
16 Followers

ONO Pharmaceutical Co Income Statement

Last quarter (Q2 2024), ONO Pharmaceutical Co's total revenue was ¥122.66B, a decrease of -11.56% from the same quarter last year. In Q2, ONO Pharmaceutical Co's net income was ¥16.85B. See ONO Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 502.67B¥ 447.19B¥ 361.36B¥ 309.28B¥ 292.42B
Gross Profit
¥ 375.55B¥ 337.13B¥ 267.85B¥ 223.71B¥ 213.36B
Operating Expenses
¥ 212.44B¥ 195.16B¥ 164.65B¥ 125.38B¥ 135.87B
Depreciation and Amortization
¥ 18.14B¥ 17.45B¥ 17.72B¥ 15.82B¥ 14.21B
EBITDA
¥ 181.98B¥ 167.50B¥ 128.54B¥ 114.54B¥ 94.00B
Operating Income
¥ 163.10B¥ 141.96B¥ 103.19B¥ 98.33B¥ 77.49B
Other Income/Expenses
¥ 630.00M¥ 1.57B¥ 1.83B¥ 2.56B¥ 516.00M
Pretax Income
¥ 163.73B¥ 143.53B¥ 105.03B¥ 100.89B¥ 79.70B
Net Income
¥ 127.98B¥ 112.72B¥ 80.52B¥ 75.42B¥ 59.70B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 266.61¥ 230.85¥ 162.19¥ 151.11¥ 118.47
Diluted EPS
¥ 266.60¥ 230.79¥ 162.16¥ 151.09¥ 118.45
Weighted Average Shares Outstanding
480.01M 488.30M 496.46M 499.14M 503.98M
Weighted Average Shares Outstanding (Diluted)
480.04M 488.35M 496.53M 499.20M 504.04M
Currency in JPY

ONO Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis